Articles
05.09.2016
Increased HTA harmonisation in the EU

The latest policy document for the European Commission outlines multiple scenarios for HTA harmonisa...

Read more
Articles
25.06.2016
German pricing and market access law changes 2017

The German Ministry of Health has recently published its final bill concerning changes to the market...

Read more
Articles
15.06.2016
The challenge in securing patient access

Enabling physicians to identify patients who are most likely to respond to treatment thereby achievi...

Read more
Publications
15.05.2016
ISPOR 2018 Achieving faster product launch

The objective of this research was to determine the national price submission procedures across Euro...

Read more
Publications
05.05.2016
Achieving Fast Product Launch

How to obtain non-reimbursed prices within the EU was presented at ISPOR's 21st annual international...

Read more
Articles
21.04.2016
Pharma preparing for NICE and EMA submissions

Pharma companies must start preparing its NICE submission at the time of making the regulatory subm...

Read more
Articles
11.04.2016
Best practices for parallel scientific advice

A best practice guide for companies seeking parallel scientific HTA advice has been published by the...

Read more
News
30.03.2016
PMA Perspectives Newsletter- March 2016

Topics include our perspectives on an EU commission report on how international reference pricing ca...

Read more
Articles
29.03.2016
Are HTA assessments here to stay

Whether ICER will become an integral part of the US healthcare landscape in the future remains to be...

Read more
Articles
15.03.2016
International reference price methodologies

This report highlights some "quick wins" that member states can quickly and easily adopt to decrease...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.